Correlation Between GeoVax Labs and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both GeoVax Labs and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeoVax Labs and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeoVax Labs and DiaMedica Therapeutics, you can compare the effects of market volatilities on GeoVax Labs and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeoVax Labs with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeoVax Labs and DiaMedica Therapeutics.
Diversification Opportunities for GeoVax Labs and DiaMedica Therapeutics
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between GeoVax and DiaMedica is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding GeoVax Labs and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and GeoVax Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeoVax Labs are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of GeoVax Labs i.e., GeoVax Labs and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between GeoVax Labs and DiaMedica Therapeutics
Given the investment horizon of 90 days GeoVax Labs is expected to generate 9.81 times less return on investment than DiaMedica Therapeutics. In addition to that, GeoVax Labs is 2.94 times more volatile than DiaMedica Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.1 per unit of volatility. If you would invest 429.00 in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of 87.00 from holding DiaMedica Therapeutics or generate 20.28% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
GeoVax Labs vs. DiaMedica Therapeutics
Performance |
Timeline |
GeoVax Labs |
DiaMedica Therapeutics |
GeoVax Labs and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GeoVax Labs and DiaMedica Therapeutics
The main advantage of trading using opposite GeoVax Labs and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeoVax Labs position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.GeoVax Labs vs. Zura Bio Limited | GeoVax Labs vs. ZyVersa Therapeutics | GeoVax Labs vs. Phio Pharmaceuticals Corp | GeoVax Labs vs. Sonnet Biotherapeutics Holdings |
DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |